VPZ Urges Government Action on Unregulated E-Cigarettes

Nov.01.2022
VPZ Urges Government Action on Unregulated E-Cigarettes
VPZ emphasizes the need for stricter control and licensing of e-cigarettes in the UK, particularly against unregulated imports.

VPZ stated that the current challenge facing the industry is the availability of unregulated imported disposable e-cigarette products in local convenience stores and supermarkets. These products are easily accessible without any regulation or control.


Doug Mutter, President of VPZ, has emphasized the importance of stricter control and regulation of electronic cigarette products. He has urged the Scottish government to take immediate action and implement measures that would require flavored products to only be sold by licensed professional e-cigarette shops that adhere to the Challenge 25 policy and provide consultation for adult smokers and e-cigarette users. In the UK, electronic cigarette products containing nicotine must be registered with the Medicines and Healthcare products Regulatory Agency (MHRA).


However, recent reports have emphasized how unregulated disposable e-cigarette products that are imported are being sold throughout the UK without any control or customer education. This poses a significant threat to the once in a lifetime opportunity for public health.


According to Doug Mutter, electronic cigarettes have had a significant impact in helping more and more people in the UK quit smoking. They have also received the support of authoritative public health agencies as an effective method for treating tobacco dependence. These agencies have recommended the inclusion and encouragement of electronic cigarettes in all treatment approaches.


The American e-cigarette market has been devastated by various factors, including a lack of regulation, posing a serious threat to the UK and potentially damaging the significant progress e-cigarettes have made in improving national health and helping the country reach its smoke-free goals. It is now crucial that we work closely with trade standards, MHRA, border forces, HMRC, NHS, and the Scottish government to address this issue.


If we are to achieve our ambitious goal of a smoke-free generation, we need to take bold and incremental steps to promote and educate the health benefits of electronic cigarettes in advertising.


Researchers from King's College London have found that vaping is more effective in quitting smoking than nicotine replacement therapy. Another report from the Royal College of Physicians Tobacco Advisory Group supports e-cigarettes as an effective treatment for tobacco dependency and suggests that they should be included in all cessation efforts and encouraged. The report also found that the long-term effects of vaping are 95% lower than smoking.


Dr. Javed Khan's recent government-commissioned review outlined recommendations for eliminating smoking and creating a smoke-free generation. The report suggests using e-cigarettes as a way to quit smoking and providing accurate information to consumers about the benefits of making the switch. VPZ hosted an event at their Sauchiehall Street store in Glasgow City Centre, launching Stoptober with interactive carbon monoxide breath tests to educate the public about their health status and reveal the effects of smoking on their bodies.


The event also includes the introduction of their Vape Clinic service, where smokers can receive specialized one-on-one consultations with e-cigarette experts from VPZ to help them quit smoking. These experts are well-trained and possess professional knowledge in interacting with smokers, promoting the health and economic benefits of switching to e-cigarettes.


VPZ, headquartered in Edinburgh, has announced that since its establishment in 2012, it has helped over 700,000 smokers quit smoking. The retailer recently launched a mobile e-cigarette clinic with celebrity ambassador Neil "Razor" Ruddock to help more people quit smoking throughout the UK. They are also calling on the UK government to ban smoking and take a proactive approach to e-cigarettes to improve public health.


Statement:


This article is compiled from third-party information and is intended only for industry communication and learning purposes.


This article does not reflect the views of 2FIRSTS and 2FIRSTS is unable to confirm the truthfulness or accuracy of the content. The translation of this article is only intended for industry communication and research purposes.


Due to limitations in the compiler's ability, the translated article may not fully reflect the original text. Therefore, it is recommended to refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan-related, or international statements and positions.


The compilation of information is copyrighted to the original media and authors. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Four CrossBar 20K disposable e-cigarettes appeared on Pennsylvania's 163-entry ENDS directory ahead of enforcement beginning October 19, 2026. The devices feature 13mL e-liquid reservoirs, 50mg/mL nicotine, 2,000mAh batteries and 0.9Ω mesh coils, with advertised puff counts of up to 20,000. CrossBar was the only modern high-puff disposable series among the directory's 15 disposable entries. Its packaging emphasizes New York design and Japanese-origin flavoring, while historical CrossBar records identify a registered U.S. tobacco manufacturing-related establishment. The link between the newer 13mL devices and earlier 1.3mL PMTA filings remains unconfirmed.
product
Oct.26
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
Global Nicotine-Pouch E-Commerce Group Haypp Shuts Sweden’s Snusnetto Over Age Verification as Identity Checks Become Industry Infrastructure for New Nicotine Products
Global Nicotine-Pouch E-Commerce Group Haypp Shuts Sweden’s Snusnetto Over Age Verification as Identity Checks Become Industry Infrastructure for New Nicotine Products
Sweden's Supreme Administrative Court has declined to hear an appeal over age verification for tobacco and nicotine products collected from parcel lockers, leaving in place a lower-court ruling that geo-located BankID verification is insufficient to securely verify the actual recipient. Haypp Group has stopped tobacco and nicotine sales through Snusnetto and is deploying a new system across its other Swedish e-commerce sites to verify the age of the person who actually opens the locker and receives the shipment. The change comes as age verification across next-generation nicotine products expands from purchase checks into retail, delivery and, for some e-cigarettes, device access itself.
Regulations
Oct.20
White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
The White House withdrew Heidi Overton's nomination to lead the U.S. Food and Drug Administration (FDA) on November 17, 2026, a day before a scheduled Senate committee vote. Overton faced questions from Republican and Democratic senators over vaccines, abortion medication and flavored nicotine products. In May, the FDA granted its first marketing authorizations for non-tobacco, non-menthol e-cigarette flavors, including mango and blueberry pods from Glas. Republican Senator Susan Collins challenged recent authorizations for flavored vaping and nicotine pouch products during Overton's September confirmation hearing. The FDA remains under Acting Commissioner Kyle Diamantas.
FDA
Nov.18
Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?
Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?
Japan Tobacco Inc. (JT) announced on November 12, 2026, that it had acquired the U.S. assets of nicotine pouch brand CLEW from Nevcore Innovations Inc., including trademarks, intellectual property, product formulations and a Premarket Tobacco Product Application (PMTA). CLEW, currently distributed through selected outlets in 13 U.S. states, will immediately join the JTI LIGGETT portfolio. The transaction follows JT's approximately $2.4 billion acquisition of U.S. cigarette maker Vector Group in 2024. JTI LIGGETT says its existing cigarette brands reach more than 160,000 U.S. retail stores. During the 2026 NACS Show in October, JTI LIGGETT booth staff told 2Firsts that the company had not yet launched nicotine pouches in the United States. Although Nevcore previously announced FDA acceptance of CLEW's PMTA, the brand is absent from the agency's current list of authorized nicotine pouch products. JT has not disclosed a retail expansion plan for CLEW.
Business
Nov.12